Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Chronic Renal Failure

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 248 articles:
HTML format

Single Articles

    January 2020
  1. TIAN R, Guo Y, Ye P, Zhang C, et al
    The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
    PLoS One. 2020;15:e0227073.
    PubMed     Abstract available

  2. HSU CC, Huang CC, Chang YC, Chen JS, et al
    A comparison of quality of life between patients treated with different dialysis modalities in Taiwan.
    PLoS One. 2020;15:e0227297.
    PubMed     Abstract available

  3. OTA Y, Kitamura M, Muta K, Yamashita H, et al
    Correction: Effect of statin on life prognosis in Japanese patients undergoing hemodialysis.
    PLoS One. 2020;15:e0228298.
    PubMed     Abstract available

  4. HSIEH HL, Hsu SC, Cheng HS, Chen CY, et al
    The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis.
    PLoS One. 2020;15:e0228405.
    PubMed     Abstract available

  5. DA COSTA LA, Andreoli MCC, Carvalho AB, Draibe SA, et al
    Clinical outcomes of incident peritoneal dialysis patients coming from kidney transplantation program: A case-control study.
    PLoS One. 2020;15:e0227870.
    PubMed     Abstract available

  6. YU IC, Fang JT, Tsai YF
    Exploring demands of hemodialysis patients in Taiwan: A two-step cluster analysis.
    PLoS One. 2020;15:e0228259.
    PubMed     Abstract available

  7. NONGNUCH A, Ngampongpan W, Srichatrapimuk S, Wongsa A, et al
    Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.
    PLoS One. 2020;15:e0227719.
    PubMed     Abstract available

  8. HOLVOET E, Vanden Wyngaert K, Van Craenenbroeck AH, Van Biesen W, et al
    The screening score of Mini Nutritional Assessment (MNA) is a useful routine screening tool for malnutrition risk in patients on maintenance dialysis.
    PLoS One. 2020;15:e0229722.
    PubMed     Abstract available

  9. FUJIMOTO K, Adachi H, Yamazaki K, Nomura K, et al
    Comparison of the pain-reducing effects of EMLA cream and of lidocaine tape during arteriovenous fistula puncture in patients undergoing hemodialysis: A multi-center, open-label, randomized crossover trial.
    PLoS One. 2020;15:e0230372.
    PubMed     Abstract available

  10. LIAO MT, Chen MK, Hsieh MY, Yeh NL, et al
    Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2020;15:e0231463.
    PubMed     Abstract available

  11. CHEN HH, Lin CH, Lai KL, Hsieh TY, et al
    Relative risk of end-stage renal disease requiring dialysis in treated ankylosing spondylitis patients compared with individuals without ankylosing spondylitis: A nationwide, population-based, matched-cohort study.
    PLoS One. 2020;15:e0231458.
    PubMed     Abstract available

  12. ZHOU H, Al-Ali F, Wang C, Hamad A, et al
    Harnessing digital health to objectively assess cognitive impairment in people undergoing hemodialysis process: The Impact of cognitive impairment on mobility performance measured by wearables.
    PLoS One. 2020;15:e0225358.
    PubMed     Abstract available

  13. SENGER RS, Sullivan M, Gouldin A, Lundgren S, et al
    Spectral characteristics of urine from patients with end-stage kidney disease analyzed using Raman Chemometric Urinalysis (Rametrix).
    PLoS One. 2020;15:e0227281.
    PubMed     Abstract available

  14. AKHTAR S, Nasir JA, Usman M, Sarwar A, et al
    The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0232931.
    PubMed     Abstract available

  15. CHANG YL, Wang JS, Yeh HC, Ting IW, et al
    Dialysis timing may be deferred toward very late initiation: An observational study.
    PLoS One. 2020;15:e0233124.
    PubMed     Abstract available

  16. LEE SW, Min HK, Chae DW, Oh KH, et al
    Indexation of left ventricular mass to predict adverse clinical outcomes in pre-dialysis patients with chronic kidney disease: KoreaN cohort study of the outcome in patients with chronic kidney disease.
    PLoS One. 2020;15:e0233310.
    PubMed     Abstract available

  17. ISMAIL MB, Al Kassaa I, El Safadi D, Al Omari S, et al
    Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon.
    PLoS One. 2020;15:e0233256.
    PubMed     Abstract available

  18. GENG X, Shi E, Wang S, Song Y, et al
    A comparative analysis of the efficacy and safety of paricalcitol versus other vitamin D receptor activators in patients undergoing hemodialysis: A systematic review and meta-analysis of 15 randomized controlled trials.
    PLoS One. 2020;15:e0233705.
    PubMed     Abstract available

  19. COLUSSI G, Brunati CCM, Gervasi F, Montoli A, et al
    A simple method for the calculation of dialysis Kt factor as a quantitative measure of removal efficiency of uremic retention solutes: Applicability to high-dialysate vs low-dialysate volume technologies.
    PLoS One. 2020;15:e0233331.
    PubMed     Abstract available

  20. KANDA E, Epureanu BI, Adachi T, Tsuruta Y, et al
    Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan.
    PLoS One. 2020;15:e0233491.
    PubMed     Abstract available

  21. AMARI Y, Morimoto S, Iida T, Takimoto H, et al
    Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study.
    PLoS One. 2020;15:e0233312.
    PubMed     Abstract available

  22. Correction: Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2020;15:e0233923.
    PubMed     Abstract available

    January 2019
  23. MATSUMOTO Y, Mori Y, Kageyama S, Arihara K, et al
    Changes in QTc interval in long-term hemodialysis patients.
    PLoS One. 2019;14:e0209297.
    PubMed     Abstract available

  24. NISHIWAKI H, Hasegawa T, Koiwa F, Hamano T, et al
    The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry.
    PLoS One. 2019;14:e0210533.
    PubMed     Abstract available

  25. SHAH S, Meganathan K, Christianson AL, Leonard AC, et al
    Pre-dialysis acute care hospitalizations and clinical outcomes in dialysis patients.
    PLoS One. 2019;14:e0209578.
    PubMed     Abstract available

  26. MURALI KM, Mullan J, Roodenrys S, Hassan HC, et al
    Strategies to improve dietary, fluid, dialysis or medication adherence in patients with end stage kidney disease on dialysis: A systematic review and meta-analysis of randomized intervention trials.
    PLoS One. 2019;14:e0211479.
    PubMed     Abstract available

  27. JEONG S, Kwon H, Chang JW, Kim MJ, et al
    Patency rates of arteriovenous fistulas created before versus after hemodialysis initiation.
    PLoS One. 2019;14:e0211296.
    PubMed     Abstract available

  28. GARNIER F, Couchoud C, Landais P, Moranne O, et al
    Increased incidence of acute kidney injury requiring dialysis in metropolitan France.
    PLoS One. 2019;14:e0211541.
    PubMed     Abstract available

  29. STEYAERT S, Holvoet E, Nagler E, Malfait S, et al
    Reporting of "dialysis adequacy" as an outcome in randomised trials conducted in adults on haemodialysis.
    PLoS One. 2019;14:e0207045.
    PubMed     Abstract available

  30. YAJIMA T, Arao M, Yajima K, Takahashi H, et al
    The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis.
    PLoS One. 2019;14:e0211988.
    PubMed     Abstract available

  31. PEDRINI LA, Zawada AM, Winter AC, Pham J, et al
    Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients.
    PLoS One. 2019;14:e0212795.
    PubMed     Abstract available

  32. GACKLER A, Rohn H, Lisman T, Benko T, et al
    Evaluation of hemostasis in patients with end-stage renal disease.
    PLoS One. 2019;14:e0212237.
    PubMed     Abstract available

  33. TAKADA D, Kunisawa S, Fushimi K, Imanaka Y, et al
    Previously-initiated hemodialysis as prognostic factor for in-hospital mortality in pneumonia patients with stage 5 chronic kidney disease: Retrospective database study of Japanese hospitals.
    PLoS One. 2019;14:e0213105.
    PubMed     Abstract available

  34. BLOCK GA, Chertow GM, Sullivan JT, Deng H, et al
    An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.
    PLoS One. 2019;14:e0213774.
    PubMed     Abstract available

  35. CHEN SW, Lu YA, Lee CC, Chou AH, et al
    Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study.
    PLoS One. 2019;14:e0212352.
    PubMed     Abstract available

  36. KOSNIK MB, Reif DM, Lobdell DT, Astell-Burt T, et al
    Associations between access to healthcare, environmental quality, and end-stage renal disease survival time: Proportional-hazards models of over 1,000,000 people over 14 years.
    PLoS One. 2019;14:e0214094.
    PubMed     Abstract available

  37. TSUJIKAWA H, Tanaka S, Matsukuma Y, Kanai H, et al
    Development of a risk prediction model for infection-related mortality in patients undergoing peritoneal dialysis.
    PLoS One. 2019;14:e0213922.
    PubMed     Abstract available

  38. KANDA E, Kato A, Masakane I, Kanno Y, et al
    A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study.
    PLoS One. 2019;14:e0214524.
    PubMed     Abstract available

  39. RENDERS L, Budde K, Rosenberger C, van Swelm R, et al
    First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis.
    PLoS One. 2019;14:e0212023.
    PubMed     Abstract available

  40. SHUKLA AM, Hinkamp C, Segal E, Ozrazgat Baslanti T, et al
    What do the US advanced kidney disease patients want? Comprehensive pre-ESRD Patient Education (CPE) and choice of dialysis modality.
    PLoS One. 2019;14:e0215091.
    PubMed     Abstract available

  41. HSU YH, Yen YC, Lin YC, Sung LC, et al
    Correction: Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study.
    PLoS One. 2019;14:e0215546.
    PubMed     Abstract available

  42. WEIDHASE L, Haussig E, Haussig S, Kaiser T, et al
    Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial.
    PLoS One. 2019;14:e0215823.
    PubMed     Abstract available

  43. KIM S, Wu F, Dahlerus C, Chyn D, et al
    Comparative effectiveness analysis of Medicare dialysis facility survey processes.
    PLoS One. 2019;14:e0216038.
    PubMed     Abstract available

  44. YI SW, Moon SJ, Yi JJ
    Low-normal hemoglobin levels and anemia are associated with increased risk of end-stage renal disease in general populations: A prospective cohort study.
    PLoS One. 2019;14:e0215920.
    PubMed     Abstract available

  45. CHOI SR, Lee YK, Cho AJ, Park HC, et al
    Malnutrition, inflammation, progression of vascular calcification and survival: Inter-relationships in hemodialysis patients.
    PLoS One. 2019;14:e0216415.
    PubMed     Abstract available

  46. CHOU MC, Ko CH, Hsieh TJ, Chang JM, et al
    A preliminary report of longitudinal white matter alterations in patients with end-stage renal disease: A three-year diffusion tensor imaging study.
    PLoS One. 2019;14:e0215942.
    PubMed     Abstract available

  47. PAN KC, Hung SY, Chen CI, Lu CY, et al
    Social support as a mediator between sleep disturbances, depressive symptoms, and health-related quality of life in patients undergoing hemodialysis.
    PLoS One. 2019;14:e0216045.
    PubMed     Abstract available

  48. WAZIRI B, Musenge E, Duarte R, Dickens C, et al
    Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease-Mineral and bone disorder with all-cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study.
    PLoS One. 2019;14:e0216656.
    PubMed     Abstract available

  49. XUE Y, Xu B, Su C, Han Q, et al
    Cardiorenal syndrome in incident peritoneal dialysis patients: What is its effect on patients' outcomes?
    PLoS One. 2019;14:e0218082.
    PubMed     Abstract available

  50. SUGANO N, Maruyama Y, Kidoguchi S, Ohno I, et al
    Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study.
    PLoS One. 2019;14:e0217859.
    PubMed     Abstract available

  51. WU PH, Lin MY, Huang TH, Lin YT, et al
    Depression amongst patients commencing maintenance dialysis is associated with increased risk of death and severe infections: A nationwide cohort study.
    PLoS One. 2019;14:e0218335.
    PubMed     Abstract available

  52. NDLOVU KCZ, Chikobvu P, Mofokeng T, Gounden V, et al
    Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis.
    PLoS One. 2019;14:e0218156.
    PubMed     Abstract available

  53. LANOT A, Bechade C, Verger C, Fabre E, et al
    Patterns of peritoneal dialysis catheter practices and technique failure in peritoneal dialysis: A nationwide cohort study.
    PLoS One. 2019;14:e0218677.
    PubMed     Abstract available

  54. SENANAYAKE S, Mahesh PKB, Gunawardena N, Graves N, et al
    Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country.
    PLoS One. 2019;14:e0211604.
    PubMed     Abstract available

  55. KHAZNEH E, Qaddumi J, Hamdan Z, Qudaimat F, et al
    The effects of Ramadan fasting on clinical and biochemical markers among hemodialysis patients: A prospective cohort study.
    PLoS One. 2019;14:e0218745.
    PubMed     Abstract available

  56. CARO MARTINEZ A, Olry de Labry Lima A, Munoz Terol JM, Mendoza Garcia OJ, et al
    Optimal start in dialysis shows increased survival in patients with chronic kidney disease.
    PLoS One. 2019;14:e0219037.
    PubMed     Abstract available

  57. ZHANG S, Morgenstern H, Albertus P, Nallamothu BK, et al
    Emergency department visits and hospitalizations among hemodialysis patients by day of the week and dialysis schedule in the United States.
    PLoS One. 2019;14:e0220966.
    PubMed     Abstract available

  58. MARTENS RJH, Broers NJH, Canaud B, Christiaans MHL, et al
    Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
    PLoS One. 2019;14:e0221058.
    PubMed     Abstract available

  59. PSTRAS L, Debowska M, Wojcik-Zaluska A, Zaluska W, et al
    Hemodialysis-induced changes in hematocrit, hemoglobin and total protein: Implications for relative blood volume monitoring.
    PLoS One. 2019;14:e0220764.
    PubMed     Abstract available

  60. YANG WL, Bose B, Zhang L, Mcstea M, et al
    Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    PLoS One. 2019;14:e0221531.
    PubMed     Abstract available

  61. INAGUMA D, Morii D, Kabata D, Yoshida H, et al
    Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients.
    PLoS One. 2019;14:e0221352.
    PubMed     Abstract available

  62. HAN BG, Kim J, Jung IY, Son JW, et al
    Relationship between volume status and possibility of pulmonary hypertension in dialysis naive CKD5 patients.
    PLoS One. 2019;14:e0221970.
    PubMed     Abstract available

  63. GRUPP C, Troche-Polzien I, Stock J, Bramlage C, et al
    Thrombophilic risk factors in hemodialysis: Association with early vascular access occlusion and patient survival in long-term follow-up.
    PLoS One. 2019;14:e0222102.
    PubMed     Abstract available

  64. HUNG TW, Huang JY, Jong GP
    Long-term outcomes of dialysis in patients with chronic kidney disease and new-onset atrial fibrillation: A population-based cohort study.
    PLoS One. 2019;14:e0222656.
    PubMed     Abstract available

  65. VALLABHAJOSYULA S, Dunlay SM, Barsness GW, Vallabhajosyula S, et al
    Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock.
    PLoS One. 2019;14:e0222894.
    PubMed     Abstract available

  66. LONDONO MC, Riveiro-Barciela M, Ahumada A, Munoz-Gomez R, et al
    Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
    PLoS One. 2019;14:e0221567.
    PubMed     Abstract available

  67. SCHMIDT-BUSBY J, Wiles J, Exeter D, Kenealy T, et al
    Self-management action and motivation of Pacific adults in New Zealand with end-stage renal disease.
    PLoS One. 2019;14:e0222642.
    PubMed     Abstract available

  68. KOMPOTIATIS P, Wiley BM, Jentzer JC, Kashani KB, et al
    Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy.
    PLoS One. 2019;14:e0209994.
    PubMed     Abstract available

  69. SUN CY, Sung JM, Wang JD, Li CY, et al
    A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis - A retrospective propensity score-matched study.
    PLoS One. 2019;14:e0223336.
    PubMed     Abstract available

  70. OOKAWARA S, Kaku Y, Ito K, Kizukuri K, et al
    Effects of dietary intake and nutritional status on cerebral oxygenation in patients with chronic kidney disease not undergoing dialysis: A cross-sectional study.
    PLoS One. 2019;14:e0223605.
    PubMed     Abstract available

  71. HOGGARD JG, Blair RD, Montero M, Moustafa MA, et al
    Clinical outcomes associated with the use of the NexSite hemodialysis catheter with new exit barrier technology: Results from a prospective, observational multi-center registry study.
    PLoS One. 2019;14:e0223285.
    PubMed     Abstract available

  72. KAIHAN AB, Hishida M, Imaizumi T, Okazaki M, et al
    Circulating levels of CD34+ cells predict long-term cardiovascular outcomes in patients on maintenance hemodialysis.
    PLoS One. 2019;14:e0223390.
    PubMed     Abstract available

  73. SURENDRA NK, Abdul Manaf MR, Hooi LS, Bavanandan S, et al
    Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis.
    PLoS One. 2019;14:e0218422.
    PubMed     Abstract available

  74. OTA Y, Kitamura M, Muta K, Yamashita H, et al
    Effect of statin on life prognosis in Japanese patients undergoing hemodialysis.
    PLoS One. 2019;14:e0224111.
    PubMed     Abstract available

  75. ETHIER I, Auger D, Beaulieu M, Wesolowska E, et al
    Evolution of high-sensitivity troponin-T and echocardiography parameters in patients undergoing high efficiency on-line hemodiafiltration versus conventional low-flux hemodialysis.
    PLoS One. 2019;14:e0223957.
    PubMed     Abstract available

  76. LI YJ, Wu HH, Liu SH, Tu KH, et al
    Polyomavirus BK, BKV microRNA, and urinary neutrophil gelatinase-associated lipocalin can be used as potential biomarkers of lupus nephritis.
    PLoS One. 2019;14:e0210633.
    PubMed     Abstract available

  77. MAEDA S, Yamaguchi M, Maeda K, Kobayashi N, et al
    Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients.
    PLoS One. 2019;14:e0224859.
    PubMed     Abstract available

  78. DUNN T, Saeed MJ, Shpigel A, Novak E, et al
    The association of preoperative cardiac stress testing with 30-day death and myocardial infarction among patients undergoing kidney transplantation.
    PLoS One. 2019;14:e0211161.
    PubMed     Abstract available

  79. NIGWEKAR SU, Pai AB, Mueller B, Dean MC, et al
    Impact of hemodialysis on the concentrations of sodium and potassium during infusion of sodium thiosulfate using an In Vitro hemodialysis model.
    PLoS One. 2019;14:e0224767.
    PubMed     Abstract available

  80. COMBES G, Damery S, Sein K, Allen K, et al
    Distress in patients with end-stage renal disease: Staff perceptions of barriers to the identification of mild-moderate distress and the provision of emotional support.
    PLoS One. 2019;14:e0225269.
    PubMed     Abstract available

  81. LIM CC, Chee ML, Cheng CY, Kwek JL, et al
    Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease.
    PLoS One. 2019;14:e0212590.
    PubMed     Abstract available

  82. TONELLI M, Wiebe N, James MT, Naugler C, et al
    Red cell distribution width associations with clinical outcomes: A population-based cohort study.
    PLoS One. 2019;14:e0212374.
    PubMed     Abstract available

  83. TER MEULEN KJ, Dekker MJE, Pasch A, Broers NJH, et al
    Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial.
    PLoS One. 2019;14:e0225824.
    PubMed     Abstract available

  84. MISAKI T, Fukunaga A, Shimizu Y, Ishikawa A, et al
    Possible link between dental diseases and arteriosclerosis in patients on hemodialysis.
    PLoS One. 2019;14:e0225038.
    PubMed     Abstract available

  85. UEDA R, Nakao M, Maruyama Y, Nakashima A, et al
    Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis.
    PLoS One. 2019;14:e0225316.
    PubMed     Abstract available

  86. HISHIDA M, Shafi T, Appel LJ, Maruyama S, et al
    Lower levels of proteinuria are associated with elevated mortality in incident dialysis patients.
    PLoS One. 2019;14:e0226866.
    PubMed     Abstract available

  87. HUGHES JT, Freeman N, Beaton B, Puruntatemeri AM, et al
    My experiences with kidney care: A qualitative study of adults in the Northern Territory of Australia living with chronic kidney disease, dialysis and transplantation.
    PLoS One. 2019;14:e0225722.
    PubMed     Abstract available

  88. BALBINO KP, Juvanhol LL, Epifanio APS, Marota LD, et al
    Dietary intake as a predictor for all-cause mortality in hemodialysis subjects (NUGE-HD study).
    PLoS One. 2019;14:e0226568.
    PubMed     Abstract available

  89. VIECELLI AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, et al
    Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
    PLoS One. 2019;14:e0213274.
    PubMed     Abstract available

  90. TITAN SM, Venturini G, Padilha K, Goulart AC, et al
    Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.
    PLoS One. 2019;14:e0213764.
    PubMed     Abstract available

  91. LIU B, Anno K, Kobayashi T, Piao J, et al
    Influence of donor liver telomere and G-tail on clinical outcome after living donor liver transplantation.
    PLoS One. 2019;14:e0213462.
    PubMed     Abstract available

  92. NIELSEN MB, Krogstrup NV, Nieuwenhuijs-Moeke GJ, Oltean M, et al
    P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation - The CONTEXT study.
    PLoS One. 2019;14:e0212676.
    PubMed     Abstract available

  93. SHI Y, Tong C, Zhang M, Gao X, et al
    Altered functional connectivity density in the brains of hemodialysis end-stage renal disease patients: An in vivo resting-state functional MRI study.
    PLoS One. 2019;14:e0227123.
    PubMed     Abstract available

  94. KIM K, Son HE, Ryu JY, Lee H, et al
    C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.
    PLoS One. 2019;14:e0215217.
    PubMed     Abstract available

  95. VAN DEN BRAND JAJG, Dijkstra TMH, Wetzels J, Stengel B, et al
    Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models.
    PLoS One. 2019;14:e0216559.
    PubMed     Abstract available

  96. SELLARS M, Clayton JM, Detering KM, Tong A, et al
    Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis.
    PLoS One. 2019;14:e0217787.
    PubMed     Abstract available

  97. THORNTON SNIDER J, Sullivan J, van Eijndhoven E, Hansen MK, et al
    Lifetime benefits of early detection and treatment of diabetic kidney disease.
    PLoS One. 2019;14:e0217487.
    PubMed     Abstract available

  98. WANG J, Chen Y, Xu W, Lu N, et al
    Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis.
    PLoS One. 2019;14:e0215362.
    PubMed     Abstract available

  99. RHIE YJ, Yoo JH, Choi JH, Chae HW, et al
    Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study.
    PLoS One. 2019;14:e0216927.
    PubMed     Abstract available

  100. MOHNEN SM, van Oosten MJM, Los J, Leegte MJH, et al
    Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
    PLoS One. 2019;14:e0220800.
    PubMed     Abstract available

  101. SYKES L, Asar O, Ritchie J, Raman M, et al
    The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease.
    PLoS One. 2019;14:e0219828.
    PubMed     Abstract available

  102. GENNIP ACEV, Broers NJH, Meulen KJT, Canaud B, et al
    Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.
    PLoS One. 2019;14:e0222547.
    PubMed     Abstract available

  103. GAN KIM SOON P, Lim SK, Rampal S, Su TT, et al
    A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants' perspective.
    PLoS One. 2019;14:e0220411.
    PubMed     Abstract available

  104. TACHIBANA S, Iyoda M, Suzuki T, Kanazawa N, et al
    Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis.
    PLoS One. 2019;14:e0224690.
    PubMed     Abstract available

  105. DUTTA P, Chaudet KM, Nazarian RM, Kroshinsky D, et al
    Correlation between clinical and pathological features of cutaneous calciphylaxis.
    PLoS One. 2019;14:e0218155.
    PubMed     Abstract available

  106. JEONG S, Kwon H, Kim JY, Kim YH, et al
    Effect of arteriovenous access closure and timing on kidney function in kidney transplant recipients.
    PLoS One. 2019;14:e0226309.
    PubMed     Abstract available

  107. VASCONCELOS ORDONES F, Pajolli PIR, Guerra da Silva R, Yamamoto HA, et al
    Impact of adjusted kidney volume measured in the bench surgery on one-year renal function in kidney transplantation.
    PLoS One. 2019;14:e0224364.
    PubMed     Abstract available

    January 2018
  108. KUO CH, Lin YL, Lee CJ, Wang CH, et al
    Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients.
    PLoS One. 2018;13:e0190694.
    PubMed     Abstract available

  109. GAYRARD N, Ficheux A, Duranton F, Guzman C, et al
    Correction: Consequences of increasing convection onto patient care and protein removal in hemodialysis.
    PLoS One. 2018;13:e0190761.
    PubMed     Abstract available

  110. CHERNG YG, Lin CS, Shih CC, Hsu YH, et al
    Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies.
    PLoS One. 2018;13:e0191155.
    PubMed     Abstract available

  111. HARM S, Schildbock C, Hartmann J
    Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.
    PLoS One. 2018;13:e0191741.
    PubMed     Abstract available

  112. ALVES FC, Sun J, Qureshi AR, Dai L, et al
    The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.
    PLoS One. 2018;13:e0190410.
    PubMed     Abstract available

  113. ISHIKAWA S, Naito S, Iimori S, Takahashi D, et al
    Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease.
    PLoS One. 2018;13:e0192990.
    PubMed     Abstract available

  114. IIMORI S, Naito S, Noda Y, Sato H, et al
    Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study.
    PLoS One. 2018;13:e0190493.
    PubMed     Abstract available

  115. WANIEWSKI J, Debowska M, Wojcik-Zaluska A, Ksiazek A, et al
    Correction: Quantification of Dialytic Removal and Extracellular Calcium Mass Balance during a Weekly Cycle of Hemodialysis.
    PLoS One. 2018;13:e0193604.
    PubMed     Abstract available

  116. ETINGER A, Kumar, Ackley W, Soiefer L, et al
    The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    PLoS One. 2018;13:e0192770.
    PubMed     Abstract available

  117. FU CF, Huang JD, Wang JT, Lin SW, et al
    The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
    PLoS One. 2018;13:e0193585.
    PubMed     Abstract available

  118. JUNG HY, Kim SH, Jang HM, Lee S, et al
    Individualized prediction of mortality using multiple inflammatory markers in patients on dialysis.
    PLoS One. 2018;13:e0193511.
    PubMed     Abstract available

  119. KOOIMAN J, de Vries JPM, Van der Heyden J, Sijpkens YWJ, et al
    Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures.
    PLoS One. 2018;13:e0189372.
    PubMed     Abstract available

  120. AOUN M, Karam R, Sleilaty G, Antoun L, et al
    Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?
    PLoS One. 2018;13:e0191541.
    PubMed     Abstract available

  121. DUONG TV, Wong TC, Chen HH, Chen TW, et al
    The cut-off values of dietary energy intake for determining metabolic syndrome in hemodialysis patients: A clinical cross-sectional study.
    PLoS One. 2018;13:e0193742.
    PubMed     Abstract available

  122. MAS S, Bosch-Panadero E, Abaigar P, Camarero V, et al
    Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration.
    PLoS One. 2018;13:e0193288.
    PubMed     Abstract available

  123. RAHMAN A, Yamazaki D, Sufiun A, Kitada K, et al
    A novel approach to adenine-induced chronic kidney disease associated anemia in rodents.
    PLoS One. 2018;13:e0192531.
    PubMed     Abstract available

  124. HAN BG, Song SH, Yoo JS, Park H, et al
    Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.
    PLoS One. 2018;13:e0195202.
    PubMed     Abstract available

  125. FUERTINGER DH, Kappel F, Zhang H, Thijssen S, et al
    Prediction of hemoglobin levels in individual hemodialysis patients by means of a mathematical model of erythropoiesis.
    PLoS One. 2018;13:e0195918.
    PubMed     Abstract available

  126. KOMENDA P, Tangri N, Klajncar E, Eng A, et al
    Patterns of emergency department utilization by patients on chronic dialysis: A population-based study.
    PLoS One. 2018;13:e0195323.
    PubMed     Abstract available

  127. REGOLISTI G, Maggiore U, Sabatino A, Gandolfini I, et al
    Interaction of healthcare staff's attitude with barriers to physical activity in hemodialysis patients: A quantitative assessment.
    PLoS One. 2018;13:e0196313.
    PubMed     Abstract available

  128. SETHI SK, Bansal SB, Khare A, Dhaliwal M, et al
    Heparin free dialysis in critically sick children using sustained low efficiency dialysis (SLEDD-f): A new hybrid therapy for dialysis in developing world.
    PLoS One. 2018;13:e0195536.
    PubMed     Abstract available

  129. PARK JY, Cho JH, Jang HM, Kim YS, et al
    Survival predictors in anuric patients on peritoneal dialysis: A prospective, multicenter, propensity score-matched cohort study.
    PLoS One. 2018;13:e0196294.
    PubMed     Abstract available

  130. GATWOOD J, Chisholm-Burns M, Davis R, Thomas F, et al
    Evidence of chronic kidney disease in veterans with incident diabetes mellitus.
    PLoS One. 2018;13:e0192712.
    PubMed     Abstract available

  131. LU W, Kwan BC, Chow KM, Pang WF, et al
    Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series.
    PLoS One. 2018;13:e0196499.
    PubMed     Abstract available

  132. FENTON A, Jesky MD, Webster R, Stringer SJ, et al
    Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease.
    PLoS One. 2018;13:e0197043.
    PubMed     Abstract available

  133. PARK JM, Lee JH, Jang HM, Park Y, et al
    Survival in patients on hemodialysis: Effect of gender according to body mass index and creatinine.
    PLoS One. 2018;13:e0196550.
    PubMed     Abstract available

  134. DUPONT V, Kanagaratnam L, Sigogne M, Bechade C, et al
    Outcome of polycystic kidney disease patients on peritoneal dialysis: Systematic review of literature and meta-analysis.
    PLoS One. 2018;13:e0196769.
    PubMed     Abstract available

  135. LIN MY, Cheng LJ, Chiu YW, Hsieh HM, et al
    Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study.
    PLoS One. 2018;13:e0198387.
    PubMed     Abstract available

  136. NAKANISHI K, Shishido K, Kumata C, Ito K, et al
    Bone density of the femoral neck in patients on maintenance dialysis.
    PLoS One. 2018;13:e0197965.
    PubMed     Abstract available

  137. KAWAI Y, Masutani K, Torisu K, Katafuchi R, et al
    Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    PLoS One. 2018;13:e0196655.
    PubMed     Abstract available

  138. LIN SY, Tu HP, Chen TC, Shen MC, et al
    Association of bacterial genotypes and epidemiological features with treatment failure in hemodialysis patients with methicillin-resistant Staphylococcus aureus bacteremia.
    PLoS One. 2018;13:e0198486.
    PubMed     Abstract available

  139. GUBENSEK J, Strobl K, Harm S, Weiss R, et al
    Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup.
    PLoS One. 2018;13:e0199204.
    PubMed     Abstract available

  140. YONEMOTO S, Hamano T, Fujii N, Shimada K, et al
    Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease.
    PLoS One. 2018;13:e0198825.
    PubMed     Abstract available

  141. REGOLISTI G, Maggiore U, Sabatino A, Gandolfini I, et al
    Correction: Interaction of healthcare staff's attitude with barriers to physical activity in hemodialysis patients: A quantitative assessment.
    PLoS One. 2018;13:e0198987.
    PubMed     Abstract available

  142. AGBAS A, Canpolat N, Caliskan S, Yilmaz A, et al
    Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children.
    PLoS One. 2018;13:e0198320.
    PubMed     Abstract available

  143. NICOLETTO BB, Pedrollo EF, Carpes LS, Coloretti NG, et al
    Progranulin serum levels in human kidney transplant recipients: A longitudinal study.
    PLoS One. 2018;13:e0192959.
    PubMed     Abstract available

  144. BORRAS SANS M, Perez-Fontan M, Martinez-Alonso M, Bajo A, et al
    Correction: The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease.
    PLoS One. 2018;13:e0200226.
    PubMed     Abstract available

  145. MIYAZAWA H, Ookawara S, Ito K, Ueda Y, et al
    Association of cerebral oxygenation with estimated glomerular filtration rate and cognitive function in chronic kidney disease patients without dialysis therapy.
    PLoS One. 2018;13:e0199366.
    PubMed     Abstract available

  146. OKAMOTO T, Hatakeyama S, Hosogoe S, Tanaka Y, et al
    Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
    PLoS One. 2018;13:e0199160.
    PubMed     Abstract available

  147. MAUNOURY F, Clement A, Nwankwo C, Levy-Bachelot L, et al
    Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France.
    PLoS One. 2018;13:e0194329.
    PubMed     Abstract available

  148. CHEN CH, Lin CL, Jeng LB
    Association between chronic pancreatitis and urolithiasis: A population-based cohort study.
    PLoS One. 2018;13:e0194019.
    PubMed     Abstract available

  149. COLL M, Ferrer-Costa C, Pich S, Allegue C, et al
    Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients.
    PLoS One. 2018;13:e0200756.
    PubMed     Abstract available

  150. LIU WS, Lai YT, Chan HL, Li SY, et al
    Associations between perfluorinated chemicals and serum biochemical markers and performance status in uremic patients under hemodialysis.
    PLoS One. 2018;13:e0200271.
    PubMed     Abstract available

  151. ETINGER A, Kumar SR, Ackley W, Soiefer L, et al
    Correction: The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    PLoS One. 2018;13:e0200980.
    PubMed     Abstract available

  152. FIGUEIREDO PHS, Lima MMO, Costa HS, Martins JB, et al
    Effects of the inspiratory muscle training and aerobic training on respiratory and functional parameters, inflammatory biomarkers, redox status and quality of life in hemodialysis patients: A randomized clinical trial.
    PLoS One. 2018;13:e0200727.
    PubMed     Abstract available

  153. IGLESIAS-ESCUDERO M, Moro-Garcia MA, Marcos-Fernandez R, Garcia-Torre A, et al
    Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
    PLoS One. 2018;13:e0194789.
    PubMed     Abstract available

  154. GOLDENSTEIN PT, Graciolli FG, Antunes GL, Dominguez WV, et al
    A prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis.
    PLoS One. 2018;13:e0198946.
    PubMed     Abstract available

  155. LOKHANDWALA S, McCague N, Chahin A, Escobar B, et al
    One-year mortality after recovery from critical illness: A retrospective cohort study.
    PLoS One. 2018;13:e0197226.
    PubMed     Abstract available

  156. LEE JY, Kim JS, Yang JW, Choi SO, et al
    Serum leptin level is associated with phase angle in CKD5 patients not undergoing dialysis.
    PLoS One. 2018;13:e0202055.
    PubMed     Abstract available

  157. RODELO-HAAD C, Rodriguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, et al
    Phosphate control in reducing FGF23 levels in hemodialysis patients.
    PLoS One. 2018;13:e0201537.
    PubMed     Abstract available

  158. MOTONISHI S, Tanaka K, Ozawa T
    Iron deficiency associates with deterioration in several symptoms independently from hemoglobin level among chronic hemodialysis patients.
    PLoS One. 2018;13:e0201662.
    PubMed     Abstract available

  159. OSHIMA M, Toyama T, Haneda M, Furuichi K, et al
    Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.
    PLoS One. 2018;13:e0201535.
    PubMed     Abstract available

  160. FERRER MD, Ketteler M, Tur F, Tur E, et al
    Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification.
    PLoS One. 2018;13:e0197061.
    PubMed     Abstract available

  161. HAMOUDA E, El-Metwally S, Tarek M
    Ant Lion Optimization algorithm for kidney exchanges.
    PLoS One. 2018;13:e0196707.
    PubMed     Abstract available

  162. FUKUMA S, Kimachi M, Omae K, Kataoka Y, et al
    Dialysis physicians' referral behaviors for hemodialysis patients suspected of having cancer: A vignette-based questionnaire study.
    PLoS One. 2018;13:e0202322.
    PubMed     Abstract available

  163. NG JK, Kwan BC, Chow KM, Pang WF, et al
    Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients.
    PLoS One. 2018;13:e0202203.
    PubMed     Abstract available

  164. GOLESTANEH L, Bellin E, Neugarten J, Lo Y, et al
    Avoidable visits to the emergency department(ED) and their association with sex, age and race in a cohort of low socio-economic status patients on hemodialysis in the Bronx.
    PLoS One. 2018;13:e0202697.
    PubMed     Abstract available

  165. HSU CK, Lee CC, Chen YT, Ting MK, et al
    Multidisciplinary predialysis education reduces incidence of peritonitis and subsequent death in peritoneal dialysis patients: 5-year cohort study.
    PLoS One. 2018;13:e0202781.
    PubMed     Abstract available

  166. KAMEI Y, Kamei D, Tsuchiya K, Mineshima M, et al
    Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients.
    PLoS One. 2018;13:e0201591.
    PubMed     Abstract available

  167. ORTEGA-PEREZ DE VILLAR L, Martinez-Olmos FJ, Junque-Jimenez A, Amer-Cuenca JJ, et al
    Test-retest reliability and minimal detectable change scores for the short physical performance battery, one-legged standing test and timed up and go test in patients undergoing hemodialysis.
    PLoS One. 2018;13:e0201035.
    PubMed     Abstract available

  168. SATO Y, Toida T, Nakagawa H, Iwakiri T, et al
    Diminishing dry weight is strongly associated with all-cause mortality among long-term maintenance prevalent dialysis patients.
    PLoS One. 2018;13:e0203060.
    PubMed     Abstract available

  169. SRIDHARAN S, Vilar E, Davenport A, Ashman N, et al
    Indexing dialysis dose for gender, body size and physical activity: Impact on survival.
    PLoS One. 2018;13:e0203075.
    PubMed     Abstract available

  170. WU HY, Huang JW, Tsai WC, Peng YS, et al
    Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: A prospective cohort study.
    PLoS One. 2018;13:e0203474.
    PubMed     Abstract available

  171. SANCHEZ-FERNANDEZ MDM, Reyes Del Paso GA, Gil-Cunquero JM, Fernandez-Serrano MJ, et al
    Executive function in end-stage renal disease: Acute effects of hemodialysis and associations with clinical factors.
    PLoS One. 2018;13:e0203424.
    PubMed     Abstract available

  172. LIU PJ, Ma F, Wang QY, He SL, et al
    The effects of oral nutritional supplements in patients with maintenance dialysis therapy: A systematic review and meta-analysis of randomized clinical trials.
    PLoS One. 2018;13:e0203706.
    PubMed     Abstract available

  173. LI L, Tang X, Kim S, Zhang Y, et al
    Effect of nocturnal hemodialysis on sleep parameters in patients with end-stage renal disease: a systematic review and meta-analysis.
    PLoS One. 2018;13:e0203710.
    PubMed     Abstract available

  174. NIU Q, Hong Y, Lee CH, Men C, et al
    Abdominal aortic calcification can predict all-cause mortality and CV events in dialysis patients: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204526.
    PubMed     Abstract available

  175. JANSZ TT, Bonenkamp AA, Boereboom FTJ, van Reekum FE, et al
    Health-related quality of life compared between kidney transplantation and nocturnal hemodialysis.
    PLoS One. 2018;13:e0204405.
    PubMed     Abstract available

  176. TSENG MF, Chou CL, Chung CH, Chien WC, et al
    Continuous veno-venous hemofiltration yields better renal outcomes than intermittent hemodialysis among traumatic intracranial hemorrhage patients with acute kidney injury: A nationwide population-based retrospective study in Taiwan.
    PLoS One. 2018;13:e0203088.
    PubMed     Abstract available

  177. FUJIWARA M, Ando I, Satoh K, Shishido Y, et al
    Biochemical evidence of cell starvation in diabetic hemodialysis patients.
    PLoS One. 2018;13:e0204406.
    PubMed     Abstract available

  178. WETMORE JB, Li S, Yan H, Xu H, et al
    Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis.
    PLoS One. 2018;13:e0203767.
    PubMed     Abstract available

  179. MOTONISHI S, Tanaka K, Ozawa T
    Correction: Iron deficiency associates with deterioration in several symptoms independently from hemoglobin level among chronic hemodialysis patients.
    PLoS One. 2018;13:e0204789.
    PubMed     Abstract available

  180. YUE Q, Yin FT, Zhang Q, Yuan C, et al
    Carious status and supragingival plaque microbiota in hemodialysis patients.
    PLoS One. 2018;13:e0204674.
    PubMed     Abstract available

  181. KIM K, Son YK, Lee SM, Kim SE, et al
    Early technical complications and long-term survival of urgent peritoneal dialysis according to break-in periods.
    PLoS One. 2018;13:e0206426.
    PubMed     Abstract available

  182. RAMAN M, Middleton RJ, Kalra PA, Green D, et al
    Outcomes in dialysis versus conservative care for older patients: A prospective cohort analysis of stage 5 Chronic Kidney Disease.
    PLoS One. 2018;13:e0206469.
    PubMed     Abstract available

  183. HSU YH, Yen YC, Lin YC, Sung LC, et al
    Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study.
    PLoS One. 2018;13:e0206011.
    PubMed     Abstract available

  184. SUWABE T, Barrera-Flores FJ, Rodriguez-Gutierrez R, Ubara Y, et al
    Effect of online hemodiafiltration compared with hemodialysis on quality of life in patients with ESRD: A systematic review and meta-analysis of randomized trials.
    PLoS One. 2018;13:e0205037.
    PubMed     Abstract available

  185. DEBOWSKA M, Poleszczuk J, Dabrowski W, Wojcik-Zaluska A, et al
    Impact of hemodialysis on cardiovascular system assessed by pulse wave analysis.
    PLoS One. 2018;13:e0206446.
    PubMed     Abstract available

  186. AKIZAWA T, Shimazaki R, Fukagawa M
    Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study.
    PLoS One. 2018;13:e0204896.
    PubMed     Abstract available

  187. MARTINEZ GARCIA MA, Fernandez Rosales MS, Lopez Dominguez E, Hernandez Velazquez Y, et al
    Telemonitoring system for patients with chronic kidney disease undergoing peritoneal dialysis: Usability assessment based on a case study.
    PLoS One. 2018;13:e0206600.
    PubMed     Abstract available

  188. PAVO N, Yarragudi R, Puttinger H, Arfsten H, et al
    Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.
    PLoS One. 2018;13:e0206830.
    PubMed     Abstract available

  189. KIKUCHI H, Kanda E, Mori T, Sato H, et al
    Short-term prognosis of emergently hospitalized dialysis-independent chronic kidney disease patients: A nationwide retrospective cohort study in Japan.
    PLoS One. 2018;13:e0208258.
    PubMed     Abstract available

  190. REHMAN IU, Munib S, Ramadas A, Khan TM, et al
    Prevalence of chronic kidney disease-associated pruritus, and association with sleep quality among hemodialysis patients in Pakistan.
    PLoS One. 2018;13:e0207758.
    PubMed     Abstract available

  191. HUGHES J, Y Y Chiu D, Kalra PA, Green D, et al
    Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    PLoS One. 2018;13:e0197400.
    PubMed     Abstract available

  192. ALLADAGBIN DJ, Fernandes PN, Tavares MB, Brito JT, et al
    The sickle cell trait and end stage renal disease in Salvador, Brazil.
    PLoS One. 2018;13:e0209036.
    PubMed     Abstract available

  193. PIETRIBIASI M, Waniewski J, Wojcik-Zaluska A, Zaluska W, et al
    Model of fluid and solute shifts during hemodialysis with active transport of sodium and potassium.
    PLoS One. 2018;13:e0209553.
    PubMed     Abstract available

  194. LEE KC, Hsu WH, Chou PH, Yiin JJ, et al
    Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study.
    PLoS One. 2018;13:e0178997.
    PubMed     Abstract available

  195. PAI M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, et al
    Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.
    PLoS One. 2018;13:e0198285.
    PubMed     Abstract available

  196. SOUWEINE JS, Kuster N, Chenine L, Rodriguez A, et al
    Physical inactivity and protein energy wasting play independent roles in muscle weakness in maintenance haemodialysis patients.
    PLoS One. 2018;13:e0200061.
    PubMed     Abstract available

  197. MCGREGOR G, Ennis S, Powell R, Hamborg T, et al
    Feasibility and effects of intra-dialytic low-frequency electrical muscle stimulation and cycle training: A pilot randomized controlled trial.
    PLoS One. 2018;13:e0200354.
    PubMed     Abstract available

  198. BORRELLI S, Chiodini P, De Nicola L, Minutolo R, et al
    Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care.
    PLoS One. 2018;13:e0202417.
    PubMed     Abstract available

  199. GRAVESEN E, Nordholm A, Mace M, Morevati M, et al
    Effect of inhibition of CBP-coactivated beta-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
    PLoS One. 2018;13:e0201936.
    PubMed     Abstract available

  200. JANSZ TT, Neradova A, van Ballegooijen AJ, Verhaar MC, et al
    The role of kidney transplantation and phosphate binder use in vitamin K status.
    PLoS One. 2018;13:e0203157.
    PubMed     Abstract available

  201. HOLM NIELSEN S, Guldager Kring Rasmussen D, Brix S, Fenton A, et al
    A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease.
    PLoS One. 2018;13:e0204239.
    PubMed     Abstract available

    Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
    PLoS One. 2018;13:e0203992.
    PubMed     Abstract available

  203. ANDREWS ES, Perrenoud L, Nowak KL, You Z, et al
    Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    PLoS One. 2018;13:e0205831.
    PubMed     Abstract available

  204. KIM IY, Kim JH, Kim MJ, Lee DW, et al
    Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease.
    PLoS One. 2018;13:e0205848.
    PubMed     Abstract available

  205. YAN B, Su X, Xu B, Qiao X, et al
    Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0206134.
    PubMed     Abstract available

  206. KOSOKU A, Uchida J, Nishide S, Kabei K, et al
    ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan.
    PLoS One. 2018;13:e0208638.
    PubMed     Abstract available

    January 2017
  207. ABE M, Hamano T, Wada A, Nakai S, et al
    Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.
    PLoS One. 2017;12:e0184424.
    PubMed     Abstract available

  208. NAKAYAMA M, Itami N, Suzuki H, Hamada H, et al
    Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation.
    PLoS One. 2017;12:e0184535.
    PubMed     Abstract available

  209. KAO CC, Yang JY, Chen L, Chao CT, et al
    Factors associated with poor outcomes of continuous renal replacement therapy.
    PLoS One. 2017;12:e0177759.
    PubMed     Abstract available

  210. YACOUB R, Nugent M, Cai W, Nadkarni GN, et al
    Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.
    PLoS One. 2017;12:e0184789.
    PubMed     Abstract available

  211. YAGUCHI A, Tatemichi S, Takeda H, Kobayashi M, et al
    PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
    PLoS One. 2017;12:e0180430.
    PubMed     Abstract available

  212. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Abstract available

  213. SEPANLOU SG, Barahimi H, Najafi I, Kamangar F, et al
    Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study.
    PLoS One. 2017;12:e0176540.
    PubMed     Abstract available

  214. SHIN DH, Lee YK, Oh J, Yoon JW, et al
    Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination.
    PLoS One. 2017;12:e0185296.
    PubMed     Abstract available

  215. NAKAZATO Y, Kurane R, Hirose S, Watanabe A, et al
    Aging and death-associated changes in serum albumin variability over the course of chronic hemodialysis treatment.
    PLoS One. 2017;12:e0185216.
    PubMed     Abstract available

  216. LITTERA R, Piredda G, Argiolas D, Lai S, et al
    KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    PLoS One. 2017;12:e0180831.
    PubMed     Abstract available

  217. WANG HH, Hung SY, Chang MY, Lee YC, et al
    Bacterial colonization patterns in daily chlorhexidine care at the exit site in peritoneal dialysis patients-A prospective, randomized controlled trial.
    PLoS One. 2017;12:e0184859.
    PubMed     Abstract available

  218. LEE JE, Lim JH, Jang HM, Kim YS, et al
    Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.
    PLoS One. 2017;12:e0185853.
    PubMed     Abstract available

  219. AOUN M, Koubar SH, Antoun L, Tamim H, et al
    Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study.
    PLoS One. 2017;12:e0185847.
    PubMed     Abstract available

  220. BURNHAM JP, Micek ST, Kollef MH
    Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.
    PLoS One. 2017;12:e0180247.
    PubMed     Abstract available

  221. BAILIE C, Kilner J, Maxwell AP, McKnight AJ, et al
    Development of next generation sequencing panel for UMOD and association with kidney disease.
    PLoS One. 2017;12:e0178321.
    PubMed     Abstract available

  222. RADAKOVIC D, Reboredo J, Helm M, Weigel T, et al
    A multilayered electrospun graft as vascular access for hemodialysis.
    PLoS One. 2017;12:e0185916.
    PubMed     Abstract available

  223. ELOOT S, Van Biesen W, Roels S, Delrue W, et al
    Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.
    PLoS One. 2017;12:e0186010.
    PubMed     Abstract available

  224. ANGERMANN S, Baumann M, Steubl D, Lorenz G, et al
    Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening.
    PLoS One. 2017;12:e0184589.
    PubMed     Abstract available

  225. ROGAN A, McCarthy K, McGregor G, Hamborg T, et al
    Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients.
    PLoS One. 2017;12:e0183926.
    PubMed     Abstract available

  226. CHO A, Lee YK, Oh J, Yoon JW, et al
    The relationship between intradialytic hypotension and vascular calcification in hemodialysis patients.
    PLoS One. 2017;12:e0185846.
    PubMed     Abstract available

  227. KSHIRSAGAR AV, Manickam RN, Mu Y, Flythe JE, et al
    Area-level poverty, race/ethnicity & dialysis star ratings.
    PLoS One. 2017;12:e0186651.
    PubMed     Abstract available

  228. KUBO Y, Imaizumi T, Ando M, Nakatochi M, et al
    Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.
    PLoS One. 2017;12:e0185476.
    PubMed     Abstract available

  229. TSAI YC, Chen HM, Hsiao SM, Chen CS, et al
    Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease.
    PLoS One. 2017;12:e0183642.
    PubMed     Abstract available

  230. MITSIDES N, Cornelis T, Broers NJH, Diederen NMP, et al
    Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease.
    PLoS One. 2017;12:e0183281.
    PubMed     Abstract available

  231. DOWER K, Zhao S, Schlerman FJ, Savary L, et al
    High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.
    PLoS One. 2017;12:e0181861.
    PubMed     Abstract available

  232. BORRAS SANS M, Perez-Fontan M, Martinez-Alonso M, Bajo A, et al
    The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease.
    PLoS One. 2017;12:e0186921.
    PubMed     Abstract available

  233. TORINO C, Pizzini P, Cutrupi S, Tripepi R, et al
    Vitamin D and methylarginines in chronic kidney disease (CKD).
    PLoS One. 2017;12:e0185449.
    PubMed     Abstract available

  234. CHIU HY, Huang WY, Ho CH, Wang JJ, et al
    Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study.
    PLoS One. 2017;12:e0180446.
    PubMed     Abstract available

  235. LANGOTE A, Hiremath S, Ruzicka M, McCormick BB, et al
    Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.
    PLoS One. 2017;12:e0187269.
    PubMed     Abstract available

  236. PIOVESAN F, Tres GS, Moreira LB, Andrades ME, et al
    Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial.
    PLoS One. 2017;12:e0186554.
    PubMed     Abstract available

  237. SIRICH TL, Aronov PA, Fullman J, Nguyen K, et al
    Untargeted mass spectrometry discloses plasma solute levels poorly controlled by hemodialysis.
    PLoS One. 2017;12:e0188315.
    PubMed     Abstract available

  238. SU X, Xu B, Yan B, Qiao X, et al
    Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.
    PLoS One. 2017;12:e0187550.
    PubMed     Abstract available

  239. ADJEI DN, Stronks K, Adu D, Snijder MB, et al
    Relationship between educational and occupational levels, and Chronic Kidney Disease in a multi-ethnic sample- The HELIUS study.
    PLoS One. 2017;12:e0186460.
    PubMed     Abstract available

  240. LIN YC, Lin JW, Wu MS, Chen KC, et al
    Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0188975.
    PubMed     Abstract available

  241. ROBERTS PR, Zachariah D, Morgan JM, Yue AM, et al
    Monitoring of arrhythmia and sudden death in a hemodialysis population: The CRASH-ILR Study.
    PLoS One. 2017;12:e0188713.
    PubMed     Abstract available

  242. WANG TL, Fang YW, Leu JG, Tsai MH, et al
    Association between serum aluminum levels and cardiothoracic ratio in patients on chronic hemodialysis.
    PLoS One. 2017;12:e0190008.
    PubMed     Abstract available

  243. HEAF J, Petersons A, Vernere B, Heiro M, et al
    Why do physicians prescribe dialysis? A prospective questionnaire study.
    PLoS One. 2017;12:e0188309.
    PubMed     Abstract available

  244. EICH G, Bartosova M, Tischer C, Wlodkowski TT, et al
    Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation.
    PLoS One. 2017;12:e0189903.
    PubMed     Abstract available

  245. CHANCHAROENTHANA W, Leelahavanichkul A, Taratummarat S, Wongphom J, et al
    Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease.
    PLoS One. 2017;12:e0187872.
    PubMed     Abstract available

  246. CUZIN L, Pugliese P, Allavena C, Rey D, et al
    Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.
    PLoS One. 2017;12:e0187517.
    PubMed     Abstract available

  247. CHERTOW GM, Block GA, Neylan JF, Pergola PE, et al
    Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease.
    PLoS One. 2017;12:e0188712.
    PubMed     Abstract available

  248. DAI L, Mukai H, Lindholm B, Heimburger O, et al
    Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.
    PLoS One. 2017;12:e0186659.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.